How TikTok’s $14 Billion U.S. Deal Will Work Under Oracle Partnership
TLDR ByteDance signed agreements to transfer control of TikTok’s U.S. operations to a new joint venture with Oracle, Silver Lake,...
Daily Market Update: Bitcoin Crosses $87K Following BOJ Rate Hike and Soft Infla...
TLDR Bitcoin jumped above $87,000 on Friday as Asian stocks rallied following Japan’s central bank raising rates to the highest le...
Crypto Analyst Warns of Potential Market Crash as Economic Indicators Align with...
TLDR: Rising unemployment and record credit card debt mirror conditions before major historical crashes Fed Funds rate remains ele...
Is Bitcoin Building a Base or Losing Momentum at Key Cost Levels?
TLDR: Bitcoin trades near TMMP, reflecting the average investor entry price and market support. AVIV ratio shows profitability and...
Can Ethereum Hold Its Key $2.8K–$3.0K Demand Zone?
TLDR: Ethereum sits at $2.8K–$3.0K, a critical demand zone for potential higher lows. Exchange supply hits lowest since 2016, redu...
Warren Buffett Steps Down: His Final Stock Picks Include Coca-Cola, Amazon, and...
TLDR Warren Buffett will step down as Berkshire Hathaway’s CEO at the end of 2025 after 55 years, making current portfolio picks h...
Amazon (AMZN) Stock: Top Investor Calls It a Bargain as OpenAI Chip Deal Emerges
TLDR Amazon stock is trading flat for 2025 despite strong business performance, with a Forward P/E around 30x that’s lower than Wa...
Microsoft (MSFT) Stock: Why This New Partnership Could Supercharge AI Revenue Gr...
TLDR Microsoft and Cognizant announced a multi-year strategic partnership to develop AI-powered solutions for global enterprises a...
PayPal (PYPL) Stock: Third Analyst Downgrade This Month Hits Payment Giant
TLDR Morgan Stanley downgraded PayPal stock from Equalweight to Underweight with a price target slashed to $51 from $74, a 31% red...
Athira Pharma (ATHA) Stock Explodes 73% Higher on Breakthrough Cancer Drug Deal
TLDR Athira Pharma stock jumped 73.4% in premarket trading after acquiring global rights to lasofoxifene, a Phase 3 breast cancer...